Cargando…
A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk
BACKGROUND: Hodgkin's lymphoma (HL) survivors who undergo radiotherapy experience increased risks of second cancers (SC) and cardiac sequelae. To reduce such risks, extended-field radiotherapy (RT) for HL has largely been replaced by involved field radiotherapy (IFRT). While it has generally be...
Autores principales: | Koh, Eng-Siew, Tran, Tu Huan, Heydarian, Mostafa, Sachs, Rainer K, Tsang, Richard W, Brenner, David J, Pintilie, Melania, Xu, Tony, Chung, June, Paul, Narinder, Hodgson, David C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1847517/ https://www.ncbi.nlm.nih.gov/pubmed/17362522 http://dx.doi.org/10.1186/1748-717X-2-13 |
Ejemplares similares
-
Comparing second cancer risk for multiple radiotherapy modalities in survivors of hodgkin lymphoma
por: Timlin, Claire, et al.
Publicado: (2021) -
Pathologic Rupture of the Spleen in Mantle-Cell-Type Non-Hodgkin's Lymphoma
por: Tan, Christopher B., et al.
Publicado: (2012) -
Case report: Composite mantle cell lymphoma and classical Hodgkin lymphoma
por: Wang, Hongyu, et al.
Publicado: (2023) -
Late effects of treatment for early-stage Hodgkin's disease.
por: Brierley, J. D., et al.
Publicado: (1998) -
Therapeutic Activity of Lenalidomide in Mantle Cell Lymphoma and Indolent Non-Hodgkin's Lymphomas
por: Gunnellini, Marco, et al.
Publicado: (2012)